Open original FDA record ↗Recall record
- FDA identifier
- Z-2405-2015
- Company in FDA record
- Cordis Corporation
- FDA classification date
- Aug 18, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential Damage may occur to the helical tip of the RENLANE Renal Denervation Catheter, if the hemostasis valve of the arterial access device is not fully open before insertion or withdrawal of the catheter.
Source facts
- Action
- Cordis sent an Urgent Field Safety Notice dated April 15, 2014 providing additional labeling to their consignees in Germany only, with a follow-up letter on August 4, 2014. Cordis explained When deploying the catheter via a compatible arterial access device, if a Tuohy-Borst type adjustable hemostasis valve is used, ensure the valve is fully open before insertion or withdrawal of the catheter. This is especially important, since the helical tip at the distal end of the RENLANE Renal Denervation Catheter has a larger diameter compared to the proximal catheter shaft. Although the event was not a Removal, all lots involved have expired. The product is no longer commercialized, and was never commercialized beyond the 10 customers in Germany.
- Initiated
- 2014-04-15
- Root cause
- Labeling Change Control
- Terminated
- 2015-08-26
- Distribution
- Distributed in Germany only.
- Recall number
- Z-2405-2015
- Recall status
- Terminated
- CDRH record ID
- 134590
- FDA classified
- 2015-08-18
- Recall event number
- 70741